In a stark warning, JPMorgan CEO Jamie Dimon highlights potential turmoil in the bond market due to escalating U.S. debt. Investors are urged to diversify as fears of a fiscal crisis loom. Discover what this means for your investments!
The U.S. manufacturing sector contracted for the third straight month in May, raising concerns among industry leaders. New orders, production, and employment continue to decline, while prices for raw materials are on the rise, creating a challenging environment for manufacturers.
Tensions between the US and China have intensified as both nations accuse each other of violating a recent trade agreement. With tariffs skyrocketing and critical mineral exports at stake, the future of their trade relations hangs in the balance.
On the first trading day of June, U.S. stock futures fell over 0.3%, despite a strong May. Treasury yields rose amid budget concerns, while crude oil prices surged after Ukraine's drone attack on Russian military airports.
China accuses the US of violating a trade truce and threatens strong measures as tensions escalate. Can a new agreement be salvaged, or is a trade war looming?
As Trump's tariffs face legal hurdles, his economic advisers remain steadfast in their belief that these duties will remain. Discover the potential ramifications of this ongoing legal saga.
Despite a recent court ruling deeming many tariffs illegal, President Trump's economic advisers are determined to maintain pressure on China, signaling no plans to extend a tariff pause. The controversial tariff strategy faces significant legal scrutiny ahead.
The US economy faced a slight contraction due to tariff impacts and reduced household spending, while Canada enjoyed a boost from exports and India surpassed growth expectations at 7.4%.
As inflation and interest rates soar, many Americans are struggling to manage their finances. With rising debt loads and increasing defaults, the economic outlook is grim for households. Discover how these factors are affecting consumers and their spending habits.
The U.S. government has canceled a crucial $770 million contract with Moderna for an avian flu vaccine, risking public health as pandemics prove to be a costly threat. Experts warn of the implications of prioritizing military spending over health security.
